NeuroKaire

Round
neurokaire.com Biotech & Healthcare Tel Aviv, Israel
Total Funding $10M
Latest Round $10M Round
Last Announced Dec 17, 2024
Investors 7 Backers
Decision Makers 5 Available

About NeuroKaire

Move beyond antidepressant trial-and-error. NeuroKaire biological testing reveals how your neurons respond to depression medication before treatment.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Round
Global Headquarters Tel Aviv, Israel
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website neurokaire.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @neurokaire (134 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $10,000,000 · Round

    fundraisingfox.com

Investors & Backers

7
European Innovation Council Fund
GreyBird Ventures
Howard Morgan
Jumpspeed Ventures
Meron Capital
Michael Zeisser
Sapir Venture Partners

Funding History

1 Round
Round equity · Dec 17, 2024

Founders & Leadership

2

Daphna Laifenfeld

CSO & Co-Founder

Work email & phone locked Unlock →

Talia Cohen Solal

CEO & Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts